GuidelineJournal of pediatric gastroenterology and nutrition2026
European Society for Paediatric Gastroenterology, Hepatology and Nutrition/North American Society for Pediatric Gastroenterology, Hepatology and Nutrition guidelines for treatment of functional constipation in children aged 0-18 years.
Guideline in Journal of pediatric gastroenterology and nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- European Society for Paediatric Gastroenterology, Hepatology and Nutrition/North American Society for Pediatric Gastroenterology, Hepatology and Nutrition guidelines for treatment of functional constipation in children aged 0-18 years.Journal of pediatric gastroenterology and nutrition · 2026Guideline
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
objectivesFunctional constipation (FC) is common in childhood, significantly impacting quality of life. Since the 2014 international guideline, new evidence has been published, and methods on making guidelines have developed. This treatment guideline for FC in children aged 0-18 years is a collaborative effort of the European and North American Societies for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN and NASPGHAN). The aim was to deliver evidence-based recommendations applicable across all treatment settings worldwide and offer methodological guidance for future research.
methodsThe guideline development followed the "Grading of Recommendations Assessment, Development and Evaluation" (GRADE) approach. The Guideline Development Group (GDG) comprised clinical experts, representing ESPGHAN, NASPGHAN and Cochrane. Prospectively agreed-upon treatments were formatted into "patient, intervention, comparison, outcome" questions. The GDG also determined decision thresholds for efficacy and safety outcomes through a Delphi process to support grading of the literature. Final recommendations were established by consensus voting, and a treatment algorithm was developed.
resultsA total of 102 original randomized controlled trials (RCTs) assessing treatment of FC in children aged 0-18 years were identified. Consensus was reached for 11 GRADE recommendations. Nineteen good practice statements were formulated, and guidance for future research methodology was proposed.
conclusionsThis guideline is the result of a collaborative effort between ESPGHAN and NASPGHAN on treatment options for FC. Systematic review of the evidence has revealed major evidence gaps for commonly used treatments for FC and highlights the need for large pediatric RCTs, particularly on treatment options with no evidence or only very low certainty evidence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.